Clinico-pathological aspects of canine cutaneous and mucocutaneous plasmacytomas

Journal of Veterinary Medicine Series A: Physiology Pathology Clinical Medicine

Volumn 49, Issue 6, 2002, Pages 307-312

  Cangul, I T ^a   Wijnen, M ^a   Van Garderen, E ^a   Van Den Ingh, T S G A M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; ANIMAL DISEASE; ARTICLE; BREEDING; CLASSIFICATION; DOG; DOG DISEASE; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MUCOSA; PATHOLOGY; PLASMACYTOMA; PROGNOSIS; SEX DIFFERENCE; SKIN TUMOR;

ANIMALS; BREEDING; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MUCOUS MEMBRANE; PLASMACYTOMA; PROGNOSIS; SEX FACTORS; SKIN NEOPLASMS;

EID: 0036675562     PISSN: 0931184X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1439-0442.2002.00456.x     Document Type: Article

References (34)

1. Arun, S. S., W. Breuer, and W. Hermanns, 1996: Immunohistochemical examination of light-chain expression (lambda/kappa ratio) in canine, feline, equine, bovine and porcine plasma cells. J. Vet. Med. A 43, 573-576.
2. Baer, K. E., A. K. Patnaik, S. R. Gilbertson, and A. I. Hurvitz, 1989: Cutaneous plasmacytomas in dogs: a morphologic and immunohistochemical study. Vet. Pathol. 26, 216-221.
3. Bartl, R., B. Frisch, R. Burkhardt, A. Fateh-Moghadam, G. Mahl. P. Gierster, M. Sund, and G. Kettner, 1982: Bone marrow histology in myeloma: its importance in diagnosis, prognosis, classification and staging. Br J. Haematol 51, 361-375.
4. Bartl, R., B. Frisch. A. Fateh-Moghadam, G. Kettner, K. Jaeger, and W. Sommerfeld, 1987: Histologic classification and staging of multiple myeloma: a retrospective and prospective study of 674 cases. Am. J. Clin. Pathol. 87, 342-355.
5. Breuer, W., F. Colbatzky. S. Platz, and W. Hermanns, 1993: Immunoglobulin-producing tumours in dogs and cats. J. Comp. Pathol. 109, 203-216.
6. Brunnert, S. R., and N. H. Altman, 1991: Identification of immunoglobulin light chains in canine extramedullary plasmacytomas by thioflavine T and immunohistochemistry. J. Vet. Diagn. Invest. 3, 245-251.
7. Cangul, I. T , E. Teske, and T. S. G. A. M. van den Ingh. 1998: Immunohistochemical staining results of frozen and paraffin embedded sections of 14 canine malignant lymphoma cases. Eur. J. Vet. Pathol 4, 17-22.
8. Carter, A., I. Hocherman, S. Linn, Y. Cohen, and I. Tatarsky. 1987: Prognostic significance of plasma cell morphology in multiple myeloma. Cancer 60, 1060-1065.
9. Clark, G. N., J. Berg, S. J. Engler, and R. T. Bronson, 1992. Extramedullary plasmacytomas in dogs: results of surgical excision in 131 cases. J Am. Anim. Hosp. Assoc. 28, 105-111.
10. De Boer, C. J., E. Schuuring, E. Dreef, G. Peters. J. Bartek, P. M. Kluin, and J. H. van Krieken, 1995: Cyclin D1 protein analysis in the diagnosis of mantle cell lymphoma. Blood 86, 2715-2723.
11. Desikan, K. R., M. V. Dhodapkar, A. Hough, T. Waldron, S. Jagannath, D. Siegel, B. Barlogie, and G. Tricot, 1997: Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation. Leuk. Lymphoma 27, 315-319.
12. Fielder, K., and B. G. M Durie. 1986: Primary amyloidosis associated with multiple myeloma. Predictors of successful therapy. Am. J. Med. 80, 413-418
13. Fritz, E., H Ludwig, and M. Kundi, 1984: Prognostic relevance of cellular morphology in multiple myeloma. Blood 63, 1072-1079.
14. Geisel, O , M. Stiglmair-Herb, and R. P. Linke, 1990: Myeloma associated with immunoglobulin lambda-light chain derived amyloid in a dog. Vet. Pathol. 27, 374-376.
15. Goasguen, J E., M. Zandecki, C. Mathiot, J.-M. Scheiff, M. Bizet, B. Ly-Sunnaram, B. Grosbois, M. Monconduit. J.-L. Michaux, and T. Facon, 1999: Mature plasma cells as indicator of better prognosis in multiple myeloma. New methodology for the assessment of plasma cell morphology. Leuk. Res. 23, 1133-1140.
16. Greipp, P. R., T. Leong. J. M. Bennett. J. P. Gaillard. B. Klein, J. A. Stewart, M. M. Oken, N. E Kay, B van Ness, and R. A. Kyle, 1998: Plasmablastic morphology: an independent prognostic factor with clinical and laboratory correlates: Eastern Cooperative Oncology Group (ECOG) myeloma trial E9486 report by the ECOG Myeloma Laboratory Group Blood 91, 2501-2507.
17. Hoechtlen-Vollmar, W., G Menzel, R. Bartl, R. Lamerz. M. Wick, and D. Seidel. 2000: Amplification of cyclin D1 gene in multiple myeloma: clinical and prognostic relevance. Br. J. Haematol. 109, 30-38.
18. Hoyer. J. D., C. A. Hanson, R. Fonseca, P. R. Greipp, G. W. Dewald, and P. J. Kurtin. 2000: The (11; 14) (q13,q32) translocation in multiple myeloma. A morphologic and immunohistochemical study. Am. J. Clin Pathol. 113, 831-837.
19. Jackson, M. W., S. C. Helfand, S. L. Smedes, G. A. Bradley, and R. D Schultz. 1994: Primary IgG secreting plasma cell tumor in the gastrointestinal tract of a dog. J. Am. Vet. Med. Assoc. 204, 404-406.
20. Kyriazidou, A., P. J. Brown, and V. M. Lucke, 1989: An immunohistochemical study of canine extramedullary plasma cell tumours J. Comp. Pathol. 100, 259-266.
21. Lucke, V. M., 1987. Primary cutaneous plasmacytomas in the dog and cat. J. Small Anim. Pract. 28, 49-55.
22. Marti, J , 1995: What is your diagnosis? Multiple osteolytic myeloma with fracture. J. Small Anim Pract. 36 (294), 304.
23. Murakami, Y., S. Tateyama, A. Rungsipipat, K. Uchida, and R. Yamaguchi, 2000: Immunohistochemical analysis of cyclin A, cyclin D1 and P53 in mammary tumors, squamous cell carcinomas and basal cell tumors of dogs and cals. J. Vet. Med. Sci. 62, 743-750.
24. Platz. S. J., W. Breuer, O. Geisel, R. P. Linke, and W. Hermanns, 1997: Identification of lambda light chain amyloid in eight canine and two feline extramedullary plasmacytomas. J. Comp. Pathol. 116, 45-54.
25. Platz. S. J., W. Breuer, S. Pfleghaar, G. Minkus, and W. Hermanns, 1999: Prognostic value of histopathological grading in canine extramedullary plasmacytomas. Vet Pathol. 36, 23-27
26. Pruneri, G., S. Fabris. L. Baldini, N. Carboni. S. Zagano. M A. Colombi. G Ciceri, L. Lombardi, M. Rocchi. R. Buffa, A. T. Maiolo, and A. Neri, 2000: Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t (11; 14). Am. J. Pathol. 156, 1505-1513.
27. Rakich, P. H., K. S. Latimer, R. Weiss, and W. L. Steffens, 1989: Mucocutaneous plasmacytomas in dogs: 75 cases (1980-87). J Am Vet. Med. Assoc. 194, 803-810.
28. Rowland, P. H., and R. P. Linke. 1994: Immunohistochemical characterization of lambda light-cham-derived amyloid in one feline and five canine plasma cell tumors. Vet. Pathol. 31, 390-393.
29. Rowland. P. H., B. A. Valentine. K. E. Stebbins, and C. A. Smith. 1991: Cutaneous plasmacytomas with amyloid in six dogs. Vet. Pathol. 28, 125-130.
30. Schwartzman, R. M., 1984: Cutaneous amyloidosis associated with a monoclonal gammopathy in a dog. J. Am. Vet. Med. Assoc. 185, 102-104.
31. Trevor, P. B., G. K. Saunders, D. R. Waldron. and M S. Leib, 1993. Metastatic extramedullary plasmacytoma of the colon and rectum in a dog. J. Am. Vet. Med. Assoc. 203, 406-409.
32. Vasef, M. A., L. J. Medeiros. L. S. Yospur, N. C. J. Sun. A. McCourty, and R. K. Brynes, 1997: Cyclin D1 protein in multiple myeloma and plasmacytoma: an immunohistochemical study using fixed, paraffin-embedded tissue sections. Mod. Pathol. 10, 927-932.
33. Xiong. Y., T. Connolly. B. Futcher, and D. Beach. 1991: Human D-type cyclin. Cell. 65, 691-699.
34. Zukerberg, L. R., W. I. Yang. A. Arnold, and N. L. Harris. 1995. Cyclin Dl expression in non-Hodgkin's lymphomas. Detection by immunohistochemistry. Am. J. Clin. Pathol. 103, 756-760.